Posted inBiotechnology
A Glimmer of Hope for Cancer Patients
A recent breakthrough in cancer research has unveiled significant insights into the mechanisms of clear cell renal cell carcinoma (ccRCC),…
Posted inBiotechnology
Mastering Gravity: Mathematicians Reveal the Impact of Shape on Hula Hooping
Hula hooping has long been seen as a playful activity, often associated with childhood and leisure. However, beneath this seemingly…
Posted inBiotechnology
Psychedelic Therapy Shows Promise in Alleviating Mental Health Issues for Cancer Patients and Addicts
Recent research has illuminated the potential benefits of psilocybin, a naturally occurring compound found in certain species of psychedelic mushrooms,…
Posted inBiotechnology
Revolutionizing Ovarian Cancer Detection: The Role of AI in Enhancing Diagnoses
A recent groundbreaking study published in the esteemed journal Nature Medicine has emerged from the innovative research team at Karolinska…
Posted inBiotechnology
Neumora stumbles at start of phase 3 depression readout run, sending stock down 80%
Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage…
Posted inBiotechnology
Valo Health abandons ROCK inhibitor after phase 2 diabetic retinopathy fail
Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading…
Posted inBiotechnology
BeiGene, Brii and Ideaya ring in 2025 with deal news, betting billions in biobucks on prospects
Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for…
Posted inBiotechnology
Cash-strapped Viracta ends phase 2 study of lead cancer drug as it mulls remaining options
Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after announcing…
Posted inBiotechnology
Pfizer cuts losses on near-approval hemophilia gene therapy, adding to troubled Sangamo’s woes
Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up…
Posted inBiotechnology
Festive biotech M&A spree sees Poolbeg combine with Hookipa, while Vincerx braces for layoffs
The festive season may be a chance to rest up and recharge—but tell that to biotech dealmakers, who have been…